Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

简要总结

详细描述

主要结局

次要结局

• Self-reported absenteeism, presenteeism, lost productivity and activity, over prior 2 weeks, measured by Work Productivity and Activity Impairment (WPAI): Specific Helath Problem (Low Back Pain) questionnaire (painPREMIER cohort)(6 months)
• All-cause absence days and costs associated with sick leave(6 months)
• painDETECT, TAMPA17 Scale for Kinesiophobia, LBPI (low back pain intensity) and RMDQ (Roland Morris Disability Questionnaire)(3 months)
• Sub-group analysis(6 months)
• Daily sleep intereference rating scale(6 months)
• Roland Morris Disability Questionnaire(6 months)
• PHQ-4 (Patient Health Questionnaire for Depression and Anxiety-4)(6 months)
• Total low back pain direct medical costs(6 months)
• Overall low back pain costs via claims data and imputed WPAI:LBP Work Productivity and Activity Impairment (WPAI): Specific Helath Problem (Low Back Pain) questionnaire(6 months)
• Specialist Occupational Health Provider Satisfaction(After enrolment complete estimated 4 months)
• Semi-structured interview(6 months)
• Specialist Occupational Health Provider Engagement(6 months)
• Specialist Occupational Health Provider treatment recommendations(6 months)
• Self-reported catastrophizing (CSQ-CAT) Coping Strategies Questionnaire - Catastrophizing scale(6 months)
• Global Assessment of Disease Activity(any time up to 6 months)
• EQ5-D Health Questionnaire(6 months)
• Self-reported low back pain intensity(3 months)
• Self-reported low back pain intensity and Roland Morris Disability Questionnaire(6 months)
• SF-12 (Short Form 12 Health Survey), v2.0 (Mental Component Summary Scale and Physical Component Summary Scale)(6 months)
• Low back pain-related medical resource use/costs and pharmacy use/costs(6 months)
• Overall all costs via claims and absence data(6 months)
• Net Promoter Score(3 months)
• Patient engagement/treatment adherence(6 months)
• Self-reported depression PHQ-8 (Patient Health Questionnaire for Depression and Anxiety-8) and anxiety GAD-7 (Generalized Anxiety Disorder 7-item scale)(6 months)
• Self-reported catastrophizing - Coping Strategies Questionnaire - Catastrophizing scale (CSQ-CAT)(3 months)
• All-cause pharmacy and medical resource use/costs(6 months)
• Low back pain-specific medical resource use/costs(6 months)
• Patient Satisfaction(6 months)
• TAMPA17 Scale for Kinesiophobia, PHQ4, PHQ8, (Patient Health Questionnaire for Depression and Anxiety-4 and 8), GAD7 (Generalized Anxiety Disorder 7-item scale)(Baseline)